April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugely popular Wegovy, are linked to suicidal thoughts, it said on Friday following a nine-month probe.

(Reporting by Manas Mishra, Eva Mathews and Bhanvi Satija in Bengaluru; Editing by Arun Koyyur and Tomasz Janowski)